Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety and effectiveness of Sarepta's gene therapy Elevidys for Duchenne Muscular Dystrophy in participants treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Elevidys (delandistrogene moxeparvovec)

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 4 | Status: NOT_YET_RECRUITING